retatrutide twice a week Timeline: Week-by-Week Results (48 Weeks) Retratuide Peptide: A Game-Changer for

In the STEP 1 trial, patients on semaglutide 2.4 mg lost an average of 14.9% of their body weight by week 68

Longer-term safety data including effects on thyroid function, pancreatitis risk, and cardiovascular outcomes are still being gathered through ongoing Phase 3 trials

Never microwave or heat artificially

Barnes notes the pill can be a great option for those transitioning to maintenance or hoping for a more flexible long-term treatment option. For some, taking a daily pill feels more sustainable than committing to weekly injections indefinitely

If you are a member of our community, you can message our specialists any time to confirm the expected appearance of your specific batch

Researchers familiar with preparing any injectable peptide will find nothing new here